Private label is faster when a validated base exists. Contract manufacturing is required when the formula, the IP or the dose is yours. Both run in the same GMP plant; the commercial model differs. This guide helps brands and pharmacies choose before the first RFQ.
Side-by-side
| Private label | Contract manufacturing | |
|---|---|---|
| Formula | Validated base / catalogue route | Yours or co-developed |
| Speed | Faster to pilot when base fits | Longer R&D and lock |
| IP | Brand/pack yours; base often plant | Custom formula per contract |
| MOQ | From 500 units | From 500 units |
| Best when | Speed, channel test, known category | Differentiation, unique dose, IP |
Choose private label when
- You need a pharmacy or e-commerce SKU quickly.
- A plant base already covers dose and claim conditions.
- Your differentiation is brand, pack and channel — not a novel matrix.
Still demand CoA, technical sheet and a clear pack brief. Speed is not an excuse for missing documents.
Choose contract manufacturing when
- The actives, ratios or delivery system are yours.
- Investors or partners require exclusive formula language.
- Taste-masking, liquids or complex blends need custom process work — see custom formulas / R&D.
Expect development cycles, pilot validation and clear IP clauses. Capacity overview: contract manufacturing.
Shared industrial realities
- Same plant, same GMP / RGSEAA frame.
- Same MOQ logic for commercial pilots.
- Same need for EFSA / AESAN-compatible labelling.
The wrong choice is promising exclusivity on a shared base, or paying custom R&D when a base already fits.
FAQ — private label vs contract manufacturing
What is private label at Comdiet?
You start from a validated base formula (or catalogue route), apply your brand and pack, and move faster to a 500-unit pilot when the base already fits your dose and claim logic.
What is contract manufacturing?
You bring (or co-develop) your own formula, dose and often your IP. The plant manufactures under GMP to your master formula. Development and validation take longer than a ready base.
Which path is cheaper?
Private label usually wins on time and early unit cost when a base exists. Contract manufacturing wins when differentiation or IP requires a unique formula — cost follows R&D and analytics, not a sticker price.
Who owns the formula IP?
Agree it in writing. Bases remain plant know-how unless the contract says otherwise. Your custom formula and trademarks stay yours when the agreement says so.
Can I switch from private label to full custom later?
Yes, but treat it as a new validation path (process, CoA, often stability). Do not assume a pack change alone upgrades a base into exclusive IP.